A qualitative study exploring the acceptability of taking part in a large multi-centre RCT of medication for anxiety in autistic adults (the STRATA trial)

Background: Autistic adults face significant health and mental health disparities, yet remain underrepresented in clinical research, with few randomised controlled trials (RCTs) to guide care. RCTs of selective serotonin reuptake inhibitors (SSRIs) in this population are limited in number, underpowered, and focused on outcomes other than anxiety. Anticipating recruitment issues in a large RCT (“STRATA”) to determine the clinical and cost effectiveness of the SSRI sertraline in reducing symptoms of anxiety in autistic adults, we embedded qualitative research to support ongoing recruitment and retention and monitor the acceptability of trial procedures in real time. Objectives: To investigate aspects of trial design and delivery that encouraged autistic adults to enrol and remain engaged with STRATA. The Theoretical Framework of Acceptability was applied to assess trial processes acceptability.Methods: 64 qualitative interviews were conducted and thematically analysed with autistic adults at various stages of trial involvement, including 2 who declined trial participation. Results: Overall, most interviewees taking part in STRATA considered trial participation acceptable because most experienced a positive affective attitude towards trial participation, and perceived the study as low burden, ethically sound, and coherent with their understanding of the methodology, as well as representing some low emotional and cognitive trade offs, providing potential benefits for themselves, and reaffirming self-efficacy relating to participation in the trial and managing their anxiety. Discussion: With 318 participants recruited across the UK and Australia, STRATA is one of the largest RCTs conducted with autistic adults with a high retention rate (92% at primary outcome, and 87% at 52 weeks). Our findings demonstrated that conducting trials with and for autistic adults is feasible. Such studies should prioritise creating accessible information and materials, consider individual communication preferences, and have meaningful involvement of autistic people throughout the research cycle, as demonstrated in STRATA, and supported by other research teams.

Authors

Publication Details

Published
2025-08-11
DOI
https://doi.org/10.31234/osf.io/w79ge_v1
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A qualitative study exploring the acceptability of taking part in a large multi-centre RCT of medication for anxiety in autistic adults (the STRATA trial)

Ava Lorenc, Jade Eloise Norris, Nicola Mills, Dheeraj Rai et al.
Autism Spectrum Disorder Research
article

A qualitative study exploring the acceptability of taking part in a large multi-centre RCT of medication for anxiety in autistic adults (the STRATA trial)

Ava Lorenc, Jade Eloise Norris, Nicola Mills, Dheeraj Rai, Alba Realpe, Aws Sadik, Zoe Morgan, STRATA Collaboration Group, Leonora Cotton
article en

Abstract

Background: Autistic adults face significant health and mental health disparities, yet remain underrepresented in clinical research, with few randomised controlled trials (RCTs) to guide care. RCTs of selective serotonin reuptake inhibitors (SSRIs) in this population are limited in number, underpowered, and focused on outcomes other than anxiety. Anticipating recruitment issues in a large RCT (“STRATA”) to determine the clinical and cost effectiveness of the SSRI sertraline in reducing symptoms of anxiety in autistic adults, we embedded qualitative research to support ongoing recruitment and retention and monitor the acceptability of trial procedures in real time. Objectives: To investigate aspects of trial design and delivery that encouraged autistic adults to enrol and remain engaged with STRATA. The Theoretical Framework of Acceptability was applied to assess trial processes acceptability.Methods: 64 qualitative interviews were conducted and thematically analysed with autistic adults at various stages of trial involvement, including 2 who declined trial participation. Results: Overall, most interviewees taking part in STRATA considered trial participation acceptable because most experienced a positive affective attitude towards trial participation, and perceived the study as low burden, ethically sound, and coherent with their understanding of the methodology, as well as representing some low emotional and cognitive trade offs, providing potential benefits for themselves, and reaffirming self-efficacy relating to participation in the trial and managing their anxiety. Discussion: With 318 participants recruited across the UK and Australia, STRATA is one of the largest RCTs conducted with autistic adults with a high retention rate (92% at primary outcome, and 87% at 52 weeks). Our findings demonstrated that conducting trials with and for autistic adults is feasible. Such studies should prioritise creating accessible information and materials, consider individual communication preferences, and have meaningful involvement of autistic people throughout the research cycle, as demonstrated in STRATA, and supported by other research teams.

Openalex Percentile: Top 79%
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.